Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillermo Chantada

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Investigational New Drugs|November 17, 2020
A decision process for drug discovery in retinoblastomaMaría Belen Cancela, Santiago Zugbi, Ursula Winter, et al.
Pediatric Blood & Cancer|March 27, 2015
SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settingsNehal S Parikh, Scott C Howard, Guillermo Chantada, et al.
Cancer|January 6, 2015
Improving our understanding of the use of traditional complementary/alternative medicine in children with cancerElena J Ladas, Meiko Lin, Federico Antillion, et al.
Pediatric Blood & Cancer|April 22, 2022
Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in ArgentinaGabriela Villanueva, Claudia Sampor, Florencia Moreno, et al.
Pediatric Blood & Cancer|January 16, 2026
Clinical Trials for Children and Adolescents With Cancer in Latin AmericaCatrian Sotelo, Margit K Mikkelsen, Oscar González-Ramella, et al.
Clinical & Developmental Immunology|September 24, 2011
Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancerAlejandra M Scursoni, Laura Galluzzo, Sandra Camarero, et al.
Journal of Global Oncology|July 2, 2019
Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric OncologistsGabriel Revon-Rivière, Shripad Banavali, Laila Heississen, et al.
Pediatric Blood & Cancer|January 4, 2018
A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP)Scott C Howard, Alan Davidson, Sandra Luna-Fineman, et al.
International Journal of Retina and Vitreous|November 1, 2017
Metastatic deaths in retinoblastoma patients treated with intraarterial chemotherapy (ophthalmic artery chemosurgery) worldwideDavid H Abramson, Carol L Shields, Pascal Jabbour, et al.
Investigative Ophthalmology & Visual Science|December 5, 2024
Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed DrugsMaría Belen Cancela, Ursula Winter, Santiago Zugbi, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Investigational New Drugs|November 17, 2020
A decision process for drug discovery in retinoblastomaMaría Belen Cancela, Santiago Zugbi, Ursula Winter, et al.
Pediatric Blood & Cancer|March 27, 2015
SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settingsNehal S Parikh, Scott C Howard, Guillermo Chantada, et al.
Cancer|January 6, 2015
Improving our understanding of the use of traditional complementary/alternative medicine in children with cancerElena J Ladas, Meiko Lin, Federico Antillion, et al.
Pediatric Blood & Cancer|April 22, 2022
Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in ArgentinaGabriela Villanueva, Claudia Sampor, Florencia Moreno, et al.
Pediatric Blood & Cancer|January 16, 2026
Clinical Trials for Children and Adolescents With Cancer in Latin AmericaCatrian Sotelo, Margit K Mikkelsen, Oscar González-Ramella, et al.
Clinical & Developmental Immunology|September 24, 2011
Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancerAlejandra M Scursoni, Laura Galluzzo, Sandra Camarero, et al.
Journal of Global Oncology|July 2, 2019
Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric OncologistsGabriel Revon-Rivière, Shripad Banavali, Laila Heississen, et al.
Pediatric Blood & Cancer|January 4, 2018
A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP)Scott C Howard, Alan Davidson, Sandra Luna-Fineman, et al.
International Journal of Retina and Vitreous|November 1, 2017
Metastatic deaths in retinoblastoma patients treated with intraarterial chemotherapy (ophthalmic artery chemosurgery) worldwideDavid H Abramson, Carol L Shields, Pascal Jabbour, et al.
Investigative Ophthalmology & Visual Science|December 5, 2024
Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed DrugsMaría Belen Cancela, Ursula Winter, Santiago Zugbi, et al.
Pageof 8